Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SOLV
Solventum Corporation (SOLV) Operating margin
Solventum Corporation's operating margin over the twelve months to 30 June 2026 was 25.0%, down 1.2 percentage points from fiscal 2025 (26.2%). That is above the Medical Instruments & Supplies industry median of 1.07% and above the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2025 | 26.2% | 13.65 |
| FY2024 | 12.6% | (8.09) |
| FY2023 | 20.6% | (0.18) |
| FY2022 | 20.8% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jun 2026 | 8.19% | 4.20 |
| Mar 2026 | 3.99% | (2.27) |
| Dec 2025 | 6.26% | (74.37) |
| Sep 2025 | 80.6% | 70.73 |
| 10 more quarters | Free account |
Operating margin against peers
| Company | Operating margin |
|---|---|
| SOLV Solventum Corporation | 25.0% |
| WST West Pharmaceutical Services, Inc. compare | 20.5% |
| ALGN Align Technology, Inc. compare | 13.2% |
| COO The Cooper Companies, Inc. compare | 12.8% |
| ATR AptarGroup, Inc. compare | 12.1% |
| ALC Alcon compare | 8.73% |
| RGEN Repligen Corporation compare | 8.23% |
| BAX Baxter International Inc. compare | −2.39% |
| AVTR Avantor, Inc. compare | −4.59% |
| Medical Instruments & Supplies industry median | 1.07% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement